Recent Quotes
My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

6.600 +0.090 (+1.38%)
Streaming Delayed Price Updated: 3:59 PM EST, Dec 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CNS Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
News headline image
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Crude Oil Down Over 3%; US Construction Spending Falls In May ↗
 
Via Benzinga
News headline image
Why CNS Pharmaceuticals Shares Are Getting Hammered ↗
CNS Pharmaceuticals shares are trading lower by 33.4% during Monday's session. The company announced a 1-for-50 reverse split of its common stock. 
Via Benzinga
News headline image
CNS Pharmaceuticals to Present at Alliance Global Partner's 2024 Healthcare Company Showcase
Via ACCESSWIRE
Virginia Tech Clinical Trial Seeks End to Brain Cancer Surgery
Via Investor Brand Network
News headline image
Nasdaq Surges 150 Points; US Manufacturing PMI Rises In May ↗
 
Via Benzinga
News headline image
CNS Pharmaceuticals Announces Reverse Stock Split
Via ACCESSWIRE
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at 2024 Healthcare Company Showcase
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases Q1 2024 Financial, Business Report
Via Investor Brand Network
News headline image
CNS Pharmaceuticals to Present at the LSX World Congress 2024
Via ACCESSWIRE
News headline image
CNS Pharmaceuticals to Participate in the Virtual Investor Lunch Break: The CNSP Opportunity
Via ACCESSWIRE
News headline image
CNSP Stock Earnings: CNS Pharmaceuticals Reported Results for Q1 2024 ↗
CNS Pharmaceuticals just reported results for the first quarter of 2024. 
Via InvestorPlace
News headline image
CNS Pharmaceuticals Reports First Quarter 2024 Financial Results
Via ACCESSWIRE
New mRNA Vaccine Offers Hope Against Glioblastoma
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
Researchers Seek to Develop Genetically Engineered Brain Cancer Treatment
Via Investor Brand Network
TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at LSX World Congress 2024
Via Investor Brand Network
New Research Sheds Light on the Initial Stages of Brain Cancer Development
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Spotlighted in Upcoming Virtual Investor Lunch Break Event
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
BioMedNewsBreaks — CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Represents Opportunity to Provide Solution for GBM Patients
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
Researchers Link Hormone Treatments to Heightened Risk of Brain Tumors
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases FY 2023 Financial Report, Corporate Update
Via Investor Brand Network
News headline image
CNSP Stock Earnings: CNS Pharmaceuticals Reported Results for Q4 2023 ↗
CNS Pharmaceuticals just reported results for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights Recent Corporate and Clinical Achievements
Via ACCESSWIRE
News headline image
CNS Pharmaceuticals to Present at Two Investor Conferences in April
Via ACCESSWIRE
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Welcomes Proven Commercialization Leader to Its Board of Directors
Via Investor Brand Network
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.